Ranbaxy divests Vietnam facility to ICA; more to follow
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has divested its manufacturing facility in Vietnam to ICA Biotechnological and Pharmaceutical, as part of ongoing rationalisation efforts.